ImmunityBio, Inc.
IBRX
$7.25
$0.081.12%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -632.78M | -61.94M | -67.25M | -92.56M | -129.65M |
| Total Depreciation and Amortization | 4.38M | 3.77M | 3.95M | 3.88M | 3.83M |
| Total Amortization of Deferred Charges | -- | 100.00K | -- | -- | -- |
| Total Other Non-Cash Items | 553.54M | 2.11M | 6.73M | 14.48M | 61.95M |
| Change in Net Operating Assets | -500.00K | -14.41M | -12.33M | -5.55M | -22.04M |
| Cash from Operations | -75.36M | -70.38M | -68.91M | -79.75M | -85.91M |
| Capital Expenditure | -1.78M | -903.00K | -741.00K | -1.08M | -1.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.87M | 44.48M | -180.62M | -15.06M | 5.25M |
| Cash from Investing | -31.65M | 43.57M | -181.36M | -16.14M | 4.13M |
| Total Debt Issued | 75.06M | 2.88M | -- | -- | -- |
| Total Debt Repaid | -881.00K | -1.14M | -12.00K | -4.00K | -- |
| Issuance of Common Stock | 156.74M | 53.74M | 173.68M | 173.14M | 220.00K |
| Repurchase of Common Stock | -6.99M | -590.00K | -151.00K | -322.00K | -1.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 223.93M | 54.89M | 173.52M | 172.81M | -982.00K |
| Foreign Exchange rate Adjustments | 122.00K | 5.00K | -56.00K | 76.00K | -10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.04M | 28.09M | -76.81M | 77.00M | -82.77M |